JPMorgan Chase & Co. Lowers Clorox (NYSE:CLX) Price Target to $95.00

Clorox (NYSE:CLX) had its price target decreased by equities researchers at JPMorgan Chase & Co. from $99.00 to $95.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 9.60% from the company’s current price.

Several other equities analysts have also recently issued reports on the stock. The Goldman Sachs Group restated a “sell” rating and set a $83.00 target price on shares of Clorox in a research note on Friday. Evercore reissued an “underperform” rating and set a $110.00 price objective on shares of Clorox in a report on Friday. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $91.00 price objective on shares of Clorox in a research report on Friday. BNP Paribas Exane raised shares of Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. Finally, Barclays set a $85.00 price target on Clorox in a report on Friday. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $105.80.

Clorox Stock Down 10.1%

CLX traded down $9.77 during trading on Friday, hitting $86.68. 10,070,124 shares of the company’s stock traded hands, compared to its average volume of 2,396,157. The stock has a market capitalization of $10.48 billion, a price-to-earnings ratio of 14.16, a PEG ratio of 0.47 and a beta of 0.65. The company’s 50 day simple moving average is $108.21 and its two-hundred day simple moving average is $108.82. Clorox has a 12-month low of $86.01 and a 12-month high of $140.24. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 383.01% and a net margin of 11.17%.The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the company posted $1.45 earnings per share. The company’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts predict that Clorox will post 5.87 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Center for Financial Planning Inc. purchased a new stake in shares of Clorox in the 3rd quarter worth $25,000. Vermillion & White Wealth Management Group LLC purchased a new position in Clorox during the third quarter valued at $25,000. Caitlin John LLC grew its holdings in Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares during the period. True Wealth Design LLC increased its position in Clorox by 1,020.0% in the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after buying an additional 204 shares in the last quarter. Finally, Root Financial Partners LLC bought a new position in shares of Clorox in the third quarter worth about $29,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Q3 beat on the headline numbers: Clorox reported $1.64 EPS vs. consensus ~ $1.55 and revenue roughly in line at ~$1.67B — showing the underlying business still delivered a modest beat. Clorox Beats Q3
• Neutral Sentiment: Management emphasized strategic innovation and selective acquisitions as a path to longer?term growth, which could support recovery over time but won’t offset near?term demand/cost headwinds immediately. Earnings Call Highlights
• Negative Sentiment: Company trimmed its fiscal outlook and cut FY2026 sales guidance (reported as a ~-6% sales outlook in market coverage), citing weaker demand and rising costs — the guidance reduction is the primary driver of the selloff and new 52?week lows. Guidance Cut / 52-Week Low
• Negative Sentiment: Major brokerages trimmed price targets (Wells Fargo to $100; Morgan Stanley to $97) and kept neutral/equal?weight stances, increasing near?term selling pressure. Wells Fargo Price Target Morgan Stanley Price Target
• Negative Sentiment: Press reports and the company update noted weaker demand and higher input costs that prompted a lower annual profit forecast, reinforcing investor concerns about near?term margins. WSJ: Cuts Earnings Outlook

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.